...
dna-img

Ginkgo Bioworks Holdings, Common Stock

DNA

NYQ

$0.8705

+$0.03

(3.56%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.44B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
NM
Volume info-icon
This is the total number of shares traded during the most recent trading day.
55.35M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
26.91M
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.36
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.81 L
$2.54 H
$0.8705

About Ginkgo Bioworks Holdings, Common Stock

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameDNASectorS&P500
1-Week Return-4.71%1.89%-0.81%
1-Month Return-20.14%-2.71%-3.95%
3-Month Return-31.46%1.31%3.35%
6-Month Return-41.58%11.93%19.7%
1-Year Return-31.46%6.35%22.93%
3-Year Return-91.61%19.71%25.5%
5-Year Return-91.4%76.38%85.41%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue54.18M76.66M313.84M477.71M251.46M[{"date":"2019-12-31","value":11.34,"profit":true},{"date":"2020-12-31","value":16.05,"profit":true},{"date":"2021-12-31","value":65.7,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":52.64,"profit":true}]
Cost of Revenue-15.61M129.69M204.22M108.81M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":7.64,"profit":true},{"date":"2021-12-31","value":63.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":53.28,"profit":true}]
Gross Profit54.18M61.05M184.15M273.49M142.64M[{"date":"2019-12-31","value":19.81,"profit":true},{"date":"2020-12-31","value":22.32,"profit":true},{"date":"2021-12-31","value":67.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":52.16,"profit":true}]
Gross Margin100.00%79.64%58.68%57.25%56.73%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":79.64,"profit":true},{"date":"2021-12-31","value":58.68,"profit":true},{"date":"2022-12-31","value":57.25,"profit":true},{"date":"2023-12-31","value":56.73,"profit":true}]
Operating Expenses125.78M198.07M2.01B2.48B814.87M[{"date":"2019-12-31","value":5.07,"profit":true},{"date":"2020-12-31","value":7.98,"profit":true},{"date":"2021-12-31","value":81.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.83,"profit":true}]
Operating Income(71.60M)(137.03M)(1.83B)(2.21B)(672.23M)[{"date":"2019-12-31","value":-7159800000,"profit":false},{"date":"2020-12-31","value":-13702700000,"profit":false},{"date":"2021-12-31","value":-182846700000,"profit":false},{"date":"2022-12-31","value":-220895200000,"profit":false},{"date":"2023-12-31","value":-67223100000,"profit":false}]
Total Non-Operating Income/Expense(44.90M)12.39M(11.19M)107.71M(165.46M)[{"date":"2019-12-31","value":-41.69,"profit":false},{"date":"2020-12-31","value":11.5,"profit":true},{"date":"2021-12-31","value":-10.39,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-153.62,"profit":false}]
Pre-Tax Income(119.83M)(124.83M)(1.84B)(2.12B)(892.94M)[{"date":"2019-12-31","value":-11983500000,"profit":false},{"date":"2020-12-31","value":-12483400000,"profit":false},{"date":"2021-12-31","value":-183812200000,"profit":false},{"date":"2022-12-31","value":-212139900000,"profit":false},{"date":"2023-12-31","value":-89294000000,"profit":false}]
Income Taxes22.00K1.89M(1.48M)(15.03M)(71.00K)[{"date":"2019-12-31","value":1.16,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-78.35,"profit":false},{"date":"2022-12-31","value":-795.5,"profit":false},{"date":"2023-12-31","value":-3.76,"profit":false}]
Income After Taxes(119.86M)(126.72M)(1.84B)(2.11B)(892.87M)[{"date":"2019-12-31","value":-11985700000,"profit":false},{"date":"2020-12-31","value":-12672300000,"profit":false},{"date":"2021-12-31","value":-183664200000,"profit":false},{"date":"2022-12-31","value":-210637200000,"profit":false},{"date":"2023-12-31","value":-89286900000,"profit":false}]
Income From Continuous Operations(119.86M)(126.72M)(1.84B)(2.11B)(854.25M)[{"date":"2019-12-31","value":-11985700000,"profit":false},{"date":"2020-12-31","value":-12672300000,"profit":false},{"date":"2021-12-31","value":-183664200000,"profit":false},{"date":"2022-12-31","value":-210637200000,"profit":false},{"date":"2023-12-31","value":-85425300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(119.86M)(126.72M)(1.84B)(2.11B)(892.87M)[{"date":"2019-12-31","value":-11985700000,"profit":false},{"date":"2020-12-31","value":-12672300000,"profit":false},{"date":"2021-12-31","value":-183664200000,"profit":false},{"date":"2022-12-31","value":-210637200000,"profit":false},{"date":"2023-12-31","value":-89286900000,"profit":false}]
EPS (Diluted)--(1.52)(1.23)(0.47)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-152,"profit":false},{"date":"2022-12-31","value":-123,"profit":false},{"date":"2023-12-31","value":-47,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DNA
Cash Ratio 5.79
Current Ratio 6.11
Quick Ratio 6.11

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DNA
ROA (LTM) -21.82%
ROE (LTM) -63.02%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DNA
Debt Ratio Lower is generally better. Negative is bad. 0.34
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.66
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 1.52

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DNA
Trailing PE NM
Forward PE NM
P/S (TTM) 8.65
P/B 1.98
Price/FCF NM
EV/R 5.85
EV/Ebitda NM
PEG NM

News

Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products

IGDI will leverage Ginkgo''s Adaptive Laboratory Evolution technology to improve its sourdough starter culture product PADUA, Italy and BOSTON, April 16, 2024 /PRNewswire/ -- Il Granaio delle Idee (IGDI), an innovative international developer and provider of clean label baking ingredients,…

16 Apr, 2024 a 11:02 am PR Newswire

Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products | DNA Stock News

Il Granaio delle Idee and Ginkgo Bioworks collaborate to enhance sourdough strains for bakery products using ALE technology. IGDI''s Pater product aims to improve flavor, aroma, and shelf life of baked goods, with Ginkgo''s support. The partnership seeks to innovate and optimize sourdough production for artisanal and industrial bakers.

16 Apr, 2024 a 11:02 am Stock Titan

Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here''s Why That''s Bullish for Both Stocks.

The collaboration could help solve challenges for both businesses.

15 Apr, 2024 a 2:00 pm The Motley Fool

Ginkgo Bioworks Announces Acquisition of AgBiome''s Platform Assets

BOSTON, April 11, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome''s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million…

11 Apr, 2024 a 11:01 am PR Newswire

Ginkgo Bioworks Announces Acquisition of AgBiome''s Platform Assets | DNA Stock News

Ginkgo Bioworks (NYSE: DNA) acquires AgBiome''s platform assets, including over 115,000 fully sequenced strains and 500 million gene sequences, enhancing Ginkgo''s ag biological discovery platform. AgBiome''s validated product concepts offer a strong foundation for future developments.

11 Apr, 2024 a 11:01 am Stock Titan

Ginkgo Bioworks Announces Expansion Of Partnership With Novo Nordisk

WASHINGTON (dpa-AFX) - Ginkgo Bioworks (DNA) announced the expansion of its strategic partnership with Novo Nordisk under a framework agreement that initially is contemplated to run over five year…

10 Apr, 2024 a 11:42 am Finanz Nachrichten

FAQs

What is Ginkgo Bioworks Holdings share price today?

Ginkgo Bioworks Holdings (DNA) share price today is $0.8705

Can Indians buy Ginkgo Bioworks Holdings shares?

Yes, Indians can buy shares of Ginkgo Bioworks Holdings (DNA) on Vested. To buy Ginkgo Bioworks Holdings from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DNA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Ginkgo Bioworks Holdings be purchased?

Yes, you can purchase fractional shares of Ginkgo Bioworks Holdings (DNA) via the Vested app. You can start investing in Ginkgo Bioworks Holdings (DNA) with a minimum investment of $1.

How to invest in Ginkgo Bioworks Holdings shares from India?

You can invest in shares of Ginkgo Bioworks Holdings (DNA) via Vested in three simple steps:

  • Click on Sign Up or Invest in DNA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Ginkgo Bioworks Holdings shares
What is Ginkgo Bioworks Holdings 52-week high and low stock price?

The 52-week high price of Ginkgo Bioworks Holdings (DNA) is $2.54. The 52-week low price of Ginkgo Bioworks Holdings (DNA) is $0.81.

What is Ginkgo Bioworks Holdings price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Ginkgo Bioworks Holdings (DNA) is NM

What is Ginkgo Bioworks Holdings price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Ginkgo Bioworks Holdings (DNA) is 1.98

What is Ginkgo Bioworks Holdings dividend yield?

The dividend yield of Ginkgo Bioworks Holdings (DNA) is 0.00%

What is the Market Cap of Ginkgo Bioworks Holdings?

The market capitalization of Ginkgo Bioworks Holdings (DNA) is $1.44B

What is Ginkgo Bioworks Holdings’s stock symbol?

The stock symbol (or ticker) of Ginkgo Bioworks Holdings is DNA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top